Dr. Louis Robert Caplan, MD

Dr. Caplan practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Caplan's NPI, 1306833561, was assigned on October 4, 2005. Dr. Caplan graduated from University of Maryland School of Medicine - Baltimore in 1962. Dr. Caplan's Massachusetts license number on file is 54320.

Dr. Caplan's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Caplan's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caplan practices. Vendor and product names are available with a free account.

Neurology is Dr. Caplan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Caplan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Caplan's licenses on file in 4 states: Massachusetts, Florida, Illinois and Maryland.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, encephalopathy, epilepsy, essential tremor, lower back pain, migraine and chronic headache and multiple sclerosis among the conditions Dr. Caplan treats.

CMS data shows 67 Medicare services from Dr. Caplan across 1 procedure code in 2024, all of them office visits, for 68 Medicare patients. Medicare paid $4,527 for them.

CMS counts 68 Medicare patients who saw Dr. Caplan in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Caplan's median patient age at 77, with 55% women.

In 2024, Dr. Caplan wrote 228 Medicare Part D claims for 61 patients. 93% of them were for generic drugs. CMS names the drug for 97 of them, across 5 drugs with 11 or more claims each, at $2,920 in total drug cost. In 2023, CMS named 214 claims across 9 drugs.

Dmand AI links 328 papers to Dr. Caplan, published from 2003 to 2024. 2016 was the busiest year, with 11. The most frequent topics are Stroke, Magnetic Resonance Imaging and Cerebrovascular Disorders. Dr. Caplan has published most often in Neurology. Dr. Caplan's most frequent co-authors are Italo Linfante, MD, Gregory W. Albers, MD and Sean Isaac Savitz, MD.

CMS Open Payments shows 22 general payments to Dr. Caplan from 2 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 100% of the total. Boehringer Ingelheim USA, Inc. paid the most, $63,111.

Dmand AI lists 6 awards for Dr. Caplan, most recently America's Top Doctors in 2014.

Dr. Caplan graduated from University of Maryland School of Medicine - Baltimore in 1962.

Dr. Caplan is in network with 4 carriers, including Aetna, United Healthcare and Molina. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.